Skip to main content

Screening for Anticancer Activity: Trypan Blue Exclusion Assay

  • Protocol
  • First Online:
Methods in Actinobacteriology

Part of the book series: Springer Protocols Handbooks ((SPH))

Abstract

Anti-cancer activity of different bacterial (actinobacterial extracts) metabolites were detrmined by cytotoxicity assay such as MTT assay, trypan blue exclusion assay, and phase contrast inverted microscope morphological assessment. IC50 (the concentration that inhibited cell growth by 50 percent) was calculated for the bacterial metabolite.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fang I-J, Brian GT (2012) Nanomedicine - Cancer, diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases. Methods Enzymol 508:41

    Article  CAS  Google Scholar 

  2. Vishnu Priya P, Rao AS (2015) Evaluation of anti-Cancer activity of tridax procumbens leaf extracts on A549 and HEP G2 Cancer cell lines. Asian J Pharma Clin Res 8-3:129

    Google Scholar 

  3. Forbes AM et al (2014) Synthesis and anticancer activity of new flavonoid analogs and inconsistencies in assays related to proliferation and viability measurements. Int J Oncol 45:831

    Article  CAS  Google Scholar 

  4. Rahman A, Choudhary MI (2019) Frontiers in anti-cancer drug discovery, vol 10. Bentham Science Publishers, Sharjah

    Book  Google Scholar 

  5. De Lima R et al (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:11

    Google Scholar 

  6. Lim HK et al (2017) DNA-dependent protein kinase modulates the anti-cancer properties of silver nanoparticles in human cancer cells. Mutat Res 824:32

    Article  CAS  Google Scholar 

  7. Ghanemi FZ et al (2017) Carob leaf polyphenols trigger intrinsic apoptotic pathway and induce cell cycle arrest in colon cancer cells. J Funct Foods 33:112

    Article  CAS  Google Scholar 

  8. Gandhi T et al (2016) Evaluation of anticancer activity of Boswellic acid and Montelukast sodium against human prostate cancer cell line PC-3. Iranian J Pharm Sci 12:15

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Madar, I., Sultan, G., Chelliah, R., Oh, DH. (2022). Screening for Anticancer Activity: Trypan Blue Exclusion Assay. In: Dharumadurai, D. (eds) Methods in Actinobacteriology. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1728-1_59

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1728-1_59

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1727-4

  • Online ISBN: 978-1-0716-1728-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics